DE69633494D1 - Verfahren zur verhinderung von transplantatabstossung - Google Patents

Verfahren zur verhinderung von transplantatabstossung

Info

Publication number
DE69633494D1
DE69633494D1 DE69633494T DE69633494T DE69633494D1 DE 69633494 D1 DE69633494 D1 DE 69633494D1 DE 69633494 T DE69633494 T DE 69633494T DE 69633494 T DE69633494 T DE 69633494T DE 69633494 D1 DE69633494 D1 DE 69633494D1
Authority
DE
Germany
Prior art keywords
donor tissue
apc
tissue
photosensitizing agent
transplant rejection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69633494T
Other languages
English (en)
Other versions
DE69633494T2 (de
Inventor
Onuora Obochi
Julia Levy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
British Columbia Vancouver British, University of
Original Assignee
University of British Columbia
QLT Inc
Quadra Logic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia, QLT Inc, Quadra Logic Technologies Inc filed Critical University of British Columbia
Publication of DE69633494D1 publication Critical patent/DE69633494D1/de
Application granted granted Critical
Publication of DE69633494T2 publication Critical patent/DE69633494T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Transplanting Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69633494T 1995-01-13 1996-01-12 Verfahren zur verhinderung von transplantatabstossung Expired - Fee Related DE69633494T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37170795A 1995-01-13 1995-01-13
US371707 1995-01-13
PCT/CA1996/000019 WO1996021466A1 (en) 1995-01-13 1996-01-12 Method to prevent transplant rejection

Publications (2)

Publication Number Publication Date
DE69633494D1 true DE69633494D1 (de) 2004-11-04
DE69633494T2 DE69633494T2 (de) 2005-10-20

Family

ID=23465087

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633494T Expired - Fee Related DE69633494T2 (de) 1995-01-13 1996-01-12 Verfahren zur verhinderung von transplantatabstossung

Country Status (18)

Country Link
EP (1) EP0804238B1 (de)
JP (1) JP3702330B2 (de)
KR (1) KR19980701317A (de)
CN (1) CN1192157A (de)
AT (1) ATE277636T1 (de)
AU (1) AU693634B2 (de)
CA (1) CA2210109C (de)
CZ (1) CZ214697A3 (de)
DE (1) DE69633494T2 (de)
ES (1) ES2227578T3 (de)
FI (1) FI972953A (de)
HU (1) HUP9801123A3 (de)
NO (1) NO973251L (de)
NZ (1) NZ298355A (de)
PL (1) PL321246A1 (de)
SK (1) SK93797A3 (de)
TW (1) TW426518B (de)
WO (1) WO1996021466A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
US5789433A (en) * 1995-01-17 1998-08-04 Quadra Logic Technologies, Inc. Green porphyrins as immunomodulators
US6096776A (en) * 1995-01-17 2000-08-01 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US6107325A (en) * 1995-01-17 2000-08-22 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US5824080A (en) * 1995-09-28 1998-10-20 The General Hospital Corporation Photochemistry for the preparation of biologic grafts--allografts and xenografts
EP0981371A1 (de) * 1997-05-16 2000-03-01 QLT Phototherapeutics, Inc. Grüne porphyrine wie immunomodulator
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6197294B1 (en) 1998-10-26 2001-03-06 Neurotech S.A. Cell surface molecule-induced macrophage activation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028594A (en) * 1988-12-27 1991-07-02 Naxcor Use of photodynamic compositions for cytotoxic effects
US5147289A (en) * 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement
US5820872A (en) * 1992-11-18 1998-10-13 Yale University Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor

Also Published As

Publication number Publication date
AU4381896A (en) 1996-07-31
FI972953A (fi) 1997-09-08
CA2210109A1 (en) 1996-07-18
JP3702330B2 (ja) 2005-10-05
EP0804238B1 (de) 2004-09-29
ATE277636T1 (de) 2004-10-15
JP2001526623A (ja) 2001-12-18
CZ214697A3 (en) 1997-12-17
CN1192157A (zh) 1998-09-02
KR19980701317A (ko) 1998-05-15
ES2227578T3 (es) 2005-04-01
NO973251D0 (no) 1997-07-11
HUP9801123A3 (en) 1999-12-28
MX9705268A (es) 1997-10-31
FI972953A0 (fi) 1997-07-11
SK93797A3 (en) 1998-01-14
PL321246A1 (en) 1997-11-24
TW426518B (en) 2001-03-21
CA2210109C (en) 2008-09-23
WO1996021466A1 (en) 1996-07-18
EP0804238A1 (de) 1997-11-05
NZ298355A (en) 2000-02-28
DE69633494T2 (de) 2005-10-20
HUP9801123A2 (hu) 1998-08-28
NO973251L (no) 1997-09-08
AU693634B2 (en) 1998-07-02

Similar Documents

Publication Publication Date Title
PT871414E (pt) Metodos para a preparacao de tecido para implantacao
DE3770190D1 (de) Beleuchtungsanordnung fuer ein system zur behandlung eines patienten durch photoaktivierung.
IL122382A0 (en) Ultra-long flashlamp-excited pulse dye laser for therapy and method therefor
CA2346644A1 (en) Method for preventing xenograft transplant rejection using photodynamic therapy
NZ334190A (en) Method for improved selectivity in photo-activation of molecular agents
AR011285A1 (es) Metodo in vitro para modificar el tejido donante, el tejido donante y un tejido de injerto obtenido por dicho metodo y una composicion de material parallevar a cabo dicho metodo.
ATE111361T1 (de) Methode für behandlung von transplantaten vor transplantationen.
ATE355099T1 (de) Vorrichtung zur photodynamischen therapie
ATE277515T1 (de) Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie
BR8707673A (pt) Processo para reproduzir medula ossea
DE69633494D1 (de) Verfahren zur verhinderung von transplantatabstossung
FI891718A (fi) Foerfarande foer att befria cellblandningar och vaevnader av icke-oenskade populationer.
EP0313901A3 (de) System zur In-Vivo-Behandlung von Tumorgeweben auf Körperoberflächen
ATE59778T1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
EP0649667A3 (de) Verfahren und Gerät zur therapeutischen Biostimulation mittels Quantenenergie
ES2043884T3 (es) Metodo de gran rendimiento para la preparacion de algodon a partir de celulas cultivadas.
DE69434691D1 (de) Zubereitung für übertragung der aktive tumorspezifische immunisierung von einem immunisiertem allogenem knochenmarkspender
ATE63695T1 (de) Bestrahlungskammer fuer ein system zur behandlung eines patienten durch photoaktivierung.
RU98100702A (ru) Способ лечения перинатальной паталогии нервной системы у новорожденных
ATE287709T1 (de) Verwendung eines protoporphyrin ix precursor zur behandlung von dermatophytosen und malaria nach photoaktivierung von diesem besagten protoporphyrin
RU97113329A (ru) Способ лечения больных с двс-синдромом и гипокоагуляцией после кровотечения при травме органов брюшной полости
UA33926A (uk) Спосіб лікування запальних процесів внутрішніх жіночих геніталій

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: UNIVERSITY OF BRITISH COLUMBIA, VANCOUVER, BRITISH

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee